Ausgabe 6/2015
Inhalt (31 Artikel)
Current and future treatment options for polycythemia vera
Martin Griesshammer, Heinz Gisslinger, Ruben Mesa
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
Juan-Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Francisco Cervantes, Alberto Alvarez-Larrán, Montse Gómez, Pere Barba, María-Isabel Mata, José-Ramón González-Porras, Francisca Ferrer-Marín, Valentín García-Gutiérrez, Elena Magro, Melania Moreno, Ana Kerguelen, Manuel Pérez-Encinas, Natàlia Estrada, Rosa Ayala, Carles Besses, Arturo Pereira
A multi-state model approach for prediction in chronic myeloid leukaemia
Michael Lauseker, Joerg Hasford, Verena S. Hoffmann, Martin C. Müller, Rüdiger Hehlmann, Markus Pfirrmann
Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis
Yang Yi-ning, Wang Xiao-rui, Zhao Chu-xian, Wang Chun, Qin You-wen
A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
E. Cassinerio, A. Roghi, N. Orofino, P. Pedrotti, L. Zanaboni, E. Poggiali, M. Giuditta, D. Consonni, M. D. Cappellini
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis
Carlos Vallejo, Pau Montesinos, Marta Polo, Beatriz Cuevas, Marta Morado, Ana Rosell, Blanca Xicoy, José L. Díez, Olga Salamero, Ángel Cedillo, Pablo Martínez, Consolación Rayón
Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis
Jia Wei, Zhiping Huang, Jingming Guo, Youshan Zhang, Chunyan Wang, Xianmin Zhu, Yicheng Zhang
Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT
Zhiyuan Zhou, Changying Chen, Xiang Li, Zhaoming Li, Xudong Zhang, Yu Chang, Lisha Lu, Yingying Cui, Yaozhen Ma, Mingzhi Zhang
Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up
Markus Raderer, Stefan Wöhrer, Barbara Kiesewetter, Werner Dolak, Heimo Lagler, Andrew Wotherspoon, Leonhard Muellauer, Andreas Chott
General features and epidemiology of lymphoma in Colombia. A multicentric study
Juan F. Combariza, Milton Lombana, Ana M. Torres, Ana M. Castellanos, Marcos Arango
Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis
K. Lerch, A. H. Meyer, A. Stroux, C. Hirt, U. Keller, A. Viardot, R. Marks, S. Schreiber, A. Pezzutto, C. W. Scholz
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis
Yasunori Kogure, Akihide Yoshimi, Koki Ueda, Yasuhito Nannya, Motoshi Ichikawa, Fumihiko Nakamura, Mineo Kurokawa
Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL
Moo-Kon Song, Joo-Seop Chung, Seong-Jang Kim, Sang-Soo Kim, Ho-Jin Shin
First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis
Andrea Messori, Valeria Fadda, Dario Maratea, Sabrina Trippoli
IgM MGUS associated with anti-MAG neuropathy: a single institution experience
Giampaolo Talamo, Muhammad A. Mir, Manoj K. Pandey, Jeffrey K. Sivik, Divisha Raheja
Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument
José Ramiro Espinoza-Zamora, César Miguel Portilla-Espinosa, Juan Rafael Labardini-Méndez, Eduardo Cervera, Ruben Niesvisky, Luis F. Oñate-Ocaña
Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease
Feng Zhu, Jianlin Qiao, Wei Chen, Bin Pan, Qing-yun Wu, Jiang Cao, Wei Sang, Zhi-ling Yan, Ling-yu Zeng, Zhen-yu Li, Kai-lin Xu
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission
John M. Magenau, Thomas Braun, Pavan Reddy, Brian Parkin, Attaphol Pawarode, Shin Mineishi, Sung Choi, John Levine, Yumeng Li, Gregory Yanik, Carrie Kitko, Tracey Churay, David Frame, Mary Mansour Riwes, Andrew Harris, Dale Bixby, Daniel R. Couriel, Steven C. Goldstein
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine
Thomas S. Y. Chan, Carol Y. M. Cheung, Ian Y. L. Yeung, Yu-Yan Hwang, Harinder Gill, Ian Y. Wong, Yok-Lam Kwong
FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse
Harinder Gill, Ho-Wan Ip, Annie W. K. Pang, Joey Sum, Anskar Y. H. leung, Yok-Lam Kwong
Disappointing response to dapsone as second line therapy for primary ITP: a case series
Thet Oo, Quentin A. Hill
Refractory mixed autoimmune hemolysis, thrombocytopenia, and thrombosis: a diagnostic puzzle
S. Klassen, M. Wang, C. Ross, M. Verhovsek
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)
Martin Henkes, Jürgen Finke, Klaus Warnatz, Sandra Ammann, Udo Zur Stadt, Gritta Janka, Wolfram Brugger
Multiple asymptomatic colon plasmacytomas: a diagnostic and therapeutic dilemma
Abhisek Swaika, Pooja P. Advani, Radhika N. Ghosh, Asit K. Jha, Liuyan Jiang, Sikander Ailawadhi
Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma
Cih-En Huang, Yi-Yang Chen, Chang-Hsien Lu, Pin-Tsung Chen, Kuan-Der Lee, Chih-Cheng Chen
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy
Venkata K. Pokuri, Bo Xu, Vishala Neppalli, Jan Czyzyk, Farid Berenji, Sarah A. Holstein, Philip L. McCarthy
Rituximab as frontline monotherapy in untreated hairy cell leukemia patients
K. Akinosoglou, M. Melachrinou, T. Makatsoris, M. Sakellakis, C. Papakonstantinou, C. A. Gogos, E. E. Solomou
Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine
P. Cougoul, E. Tournier, K. Delavigne, O. Beyne Rauzy, L. Ysebaert, V. Sibaud
Recurrence of persistent polyclonal B lymphocytosis (PPBL) after rituximab treatment
C. Wehr, L. Houet, M. Pantic, S. Gutenberger, F. Emmerich, R. Marks, P. Fisch, Klaus Warnatz
Hepatosplenic γδ T-cell lymphoma after allogeneic bone marrow transplantation
Marie-Christiane Vekemans, Lucienne Michaux, Pascale Saussoy, Eric Van Den Neste, Ivan Théate, Augustin Ferrant
Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib
Emanuele Ammatuna, Matthias Eefting, Kirsten van Lom, François G. Kavelaars, Peter J. M. Valk, Ivo P. Touw